documents: FDA-2024-N-2980-0006

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2024-N-2980-0006 FDA FDA-2024-N-2980 Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-On Recombinant Peptide Products; Reopening of the Comment Period Notice Extension of Comment Period 2024-12-31T05:00:00Z 2024 12 2024-12-31T05:00:00Z   2024-12-31T14:48:35Z 2024-31365 0 0 0900006486896ad4

Links from other tables